RxDoctor Payments Data

Rex Harris, MD

Family Medicine · Waco, TXNPI 1861804627

Payments from drug & device makers

$5,072in general payments, 2019–2025

Across 368 payments — averaging $13.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • AbbVie$726
  • Amgen$507
  • Novo Nordisk$481
  • Pfizer$319
  • Johnson & Johnson$199
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$4,98698%
  • Education$70%
  • Other$782%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,072 in reported general payments places this provider in the 85th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$46,307
Medicare patients
319
Services billed
2,292

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter82$110,550
EliquisApixaban133$98,001
OzempicSemaglutide75$89,312
MounjaroTirzepatide50$72,283
JanuviaSitagliptin Phosphate111$63,508
Breztri AerosphereBudesonide/Glycopyr/Formoterol67$55,688
RybelsusSemaglutide35$45,353
EntrestoSacubitril/Valsartan49$37,618
TrulicityDulaglutide34$37,062
JardianceEmpagliflozin56$36,296
Soliqua 100-33Insulin Glargine/Lixisenatide34$32,481
ProliaDenosumab18$30,856
XareltoRivaroxaban28$28,520
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog21$26,703
XifaxanRifaximin16$26,011

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$481$134,666110 claims
GSKTrelegy Ellipta, Breo Ellipta$1,008$120,198102 claims
Lilly USA, LLCMounjaro, Trulicity$84$109,34584 claims
PfizerEliquis, Premarin$319$107,194146 claims
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort$75$79,134110 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta$103$65,92292 claims
MerckJanuvia$15$63,508111 claims
NovartisEntresto$13$37,61849 claims
AmgenProlia$507$30,85618 claims
Johnson & JohnsonXarelto$199$28,52028 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$162$26,01116 claims
AbbVieLinzess$726$23,62135 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Waco

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →